My final lifeline" | The Biomedical Scientist Magazine of the IBMS
The Institute of Cancer Research - Professor Kevin Harrington (ICR + Royal Marsden NHS Foundation Trust) responds to today's news of the 2018 Nobel Prize for Physiology or Medicine being awarded to
Game-changing drug doubles head and neck cancer survival | The Royal Marsden
RM Magazine - Winter 2022 by The Royal Marsden - Issuu
Royal Marsden staff among world's top influential researchers | The Royal Marsden Cancer Charity
World's first centre for recurrent head and neck cancer launched - Professor Christopher Nutting Oncology
Kevin Harrington - Reader in Biological Cancer Therapies - Institute of Cancer Research | LinkedIn
Kevin Harrington | Obstetrician & Gynaecologist in London - Doctify
RM Magazine - spring 2012 - The Royal Marsden
Professor Kevin Harrington - The Institute of Cancer Research, London
Improved survival, toxicity & QoL with pembrolizumab in head and neck cancer - YouTube
Scientific Lecture | Kevin Harrington | FRONTAL
Scientific Advisory Board – PsiVac
Immunotherapy for recurrent or metastatic HNSCC: What are the practical considerations? - touchONCOLOGY
The 7th Annual Royal Marsden Head and Neck Conference | HealthManagement.org
Kevin Harrington | Oncologist in Sutton - Doctify
Professor Kevin Harrington to star in BBC2's Trust me, I'm a Doctor - The Institute of Cancer Research, London
Kevin Harrington, PhD on KEYNOTE-048: What Is The Second-...
ICR researchers named among world's most influential scientists - The Institute of Cancer Research, London
Potential of immunotherapy in head and neck cancer | VJOncology
Using Viruses to Treat Cancer | Prof Kevin Harrington | #SCIPEL 2015 | SCI - YouTube
Kevin Harrington | Oncologist in Sutton - Doctify
Professor Kevin Harrington - The Institute of Cancer Research, London
Potential of immunotherapy in head and neck cancer | VJOncology
Royal Marsden researchers named among world's most influential scientists | The Royal Marsden
